Safety and Efficacy of Acalabrutinib, Bendamustine, and Rituximab in Patients with Treatment‐Naive or Relapsed/Refractory Mantle Cell Lymphoma: Phase Ib Trial von Phillips, T., Wang, M., Robak, T., Gallinson, D., Stevens, D., Patel, K., Ramadan, S., Wun, C., Jurczak, W., Smith, S. D.

Volltext

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202 von Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G.M., Melisi, D., Al Rajabi, R.M., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Veronese, M.L., Abou-Alfa, G.K.

Volltext

O-2 Pemigatinib for previously treated locally advanced or metastatic cholangiocarcinoma: Final results from FIGHT-202 von Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, S., Borad, M., Gallinson, D., Murphy, A., Oh, D., Dotan, E., Catenacci, D., Van Cutsem, E., Lihou, C., Zhen, H., Veronese, L., Abou-Alfa, G.

Volltext

SO-4 Progression-free survival in patients with cholangiocarcinoma with FGFR2 fusions or rearrangements: A FIGHT-202 post-hoc analysis of prior systemic therapy response von Abou-Alfa, G., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A., Borad, M., Gallinson, D., Murphy, A., Oh, D., Dotan, E., Catenacci, D., Van Cutsem, E., Lihou, C., Ren, H., Bibeau, K., Feliz, L., Vogel, A.

Volltext

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 von Phillips, T, Wang, M, Robak, T, Gallinson, D, Stevens, D, Patel, K, Ramadan, S, Wun, C, Jurczak, W, Smith, S D

Volltext

FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) von Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Féliz, L., Abou-Alfa, G.K.

Volltext

LBA40 - FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) von Vogel, A., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A.S., Borad, M.J., Gallinson, D., Murphy, A.G., Oh, D.-Y., Dotan, E., Catenacci, D.V., Van Cutsem, E., Lihou, C.F., Zhen, H., Féliz, L., Abou-Alfa, G.K.

Volltext

LBA40FIGHT-202: A phase II study of pemigatinib in patients (pts) with previously treated locally advanced or metastatic cholangiocarcinoma (CCA) von Vogel, A, Sahai, V, Hollebecque, A, Vaccaro, G, Melisi, D, Al-Rajabi, R, Paulson, A S, Borad, M J, Gallinson, D, Murphy, A G, Oh, D-Y, Dotan, E, Catenacci, D V, Van Cutsem, E, Lihou, C F, Zhen, H, Féliz, L, Abou-Alfa, G K

Volltext

Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial von Phillips, Tycel, Wang, Michael, Robak, Tadeusz, Gallinson, David, Stevens, Don, Patel, Krish, Ramadan, Safaa, Wun, Chuan-Chuan, Jurczak, Wojciech, Smith, Stephen D

Volltext

Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naïve (TN) Mantle Cell Lymphoma (MCL): 2-Year Safety and Efficacy Analysis von Wang, Michael, Robak, Tadeusz, Maddocks, Kami J., Phillips, Tycel, Smith, Stephen D., Gallinson, David, Calvo, Roser, Wun, Chuan-Chuan, Munugalavadla, Veerendra, Jurczak, Wojciech

Volltext

Safety and Efficacy of Acalabrutinib Plus Venetoclax and Rituximab in Patients with Treatment-Naïve (TN) Mantle Cell Lymphoma (MCL) von Wang, Michael, Robak, Tadeusz, Maddocks, Kami J., Phillips, Tycel, Smith, Stephen D., Gallinson, David, Calvo, Roser, Wun, Chuan-Chuan, Munugalavadla, Veerendra, Jurczak, Wojciech

Volltext

P1094: SAFETY AND EFFICACY OF ACALABRUTINIB, BENDAMUSTINE, AND RITUXIMAB IN PATIENTS WITH TREATMENT‐NAIVE OR RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: PHASE IB TRIAL von Phillips, Tycel, Wang, Michael, Robak, Tadeusz, Gallinson, David, Stevens, Don, Patel, Krish, Ramadan, Safaa, Wun, Chuan‐Chaun, Jurczak, Wojciech, Smith, Stephen D.

Volltext

Acalabrutinib plus venetoclax and rituximab in treatment-naive mantle cell lymphoma: 2-year safety and efficacy analysis von Wang, Michael, Robak, Tadeusz, Maddocks, Kami J., Phillips, Tycel, Smith, Stephen D., Gallinson, David, Calvo, Roser, Wun, Chuan-Chuan, Munugalavadla, Veerendra, Jurczak, Wojciech

Volltext